OnWebPurdue Pharma Squares Off With DOJ Over $6 Billion OxyContin DealPurdue Pharma Squares Off With DOJ Over $6 Billion OxyContin DealUpdated on 29 April 2022, 11:11 PMPublished on 29 April 2022, 5:30 PM